VCREDIT(02003) was granted a discount of about 9.09% by the chairman to proceed with the takeover offer. It will resume trading on December 23rd.
VCREDIT (02003) announced that trading of the company's shares will resume at 9:00 a.m. on December 23, 2024.
WAI CHUN BIOTEC (00660) shareholders' loss for the year was HK$44.212 million, an increase of 1.86 times year-on-year. Trading will resume on December 23rd.
Jicheng Pharmaceutical (02616) submits clinical trial application for its flagship product CS2009 (PD-1/VEGF/CTLA-4 triple antibody) in Australia.
©️2013 - 2025 GMT EIGHT Holdings. All Rights Reserved.
Contact: contact@gmteight.com